Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

621.039.8 --- 539.163 --- Applications of isotopes generally: radioisotopes, stable isotopes --- Radionuclides and their characteristics. Decay schemata. Half-life. Energy spectrum --- 539.163 Radionuclides and their characteristics. Decay schemata. Half-life. Energy spectrum --- 621.039.8 Applications of isotopes generally: radioisotopes, stable isotopes --- Radioisotopes --- Safety measures

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This work focuses on new electromagnetic decay mode in nuclear physics. The first part of the thesis presents the observation of the two-photon decay for a transition where the one-photon decay is allowed. In the second part, so called quadrupole mixed-symmetry is investigated in inelastic proton scattering experiments. In 1930 Nobel-prize winner M. Goeppert-Mayer was the first to discuss the two-photon decay of an exited state in her doctoral thesis. This process has been observed many times in atomic physics. However in nuclear physics data is sparse. Here this decay mode has only been observed for the special case of a transition between nuclear states with spin and parity quantum number 0+. For such a transition, the one-photon decay – the main experimental obstacle to observe the two-photon decay – is forbidden. Furthermore, the energy sharing and angular distributions were measured, allowing conclusions to be drawn about the multipoles contributing to the two-photon transition. Quadrupole mixed-symmetry states are an excitation mode in spherical nuclei which are sensitive to the strength of the quadrupole residual interaction. A new signature for these interesting states is presented which allows identification of mixed-symmetry states independently of electromagnetic transition strengths. Furthermore this signature represents a valuable additional observable to test model predictions for mixed-symmetry states.

Nuclear Physics --- Electricity & Magnetism --- Physics --- Physical Sciences & Mathematics --- Photons --- Radioactive decay. --- Nuclear isomers. --- Scattering. --- Isomerism (Nuclear physics) --- Isomers, Nuclear --- Isomers (Nuclear physics) --- Decay, Radioactive --- Radioactive disintegration --- Nuclear physics --- Nuclides --- Half-life (Nuclear physics) --- Nuclear reactions --- Radioactivity --- Scattering (Physics) --- Nuclear physics. --- Nuclear Physics, Heavy Ions, Hadrons. --- Theoretical, Mathematical and Computational Physics. --- Atomic nuclei --- Atoms, Nuclei of --- Nucleus of the atom --- Heavy ions. --- Mathematical physics. --- Physical mathematics --- Ions --- Mathematics

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Targeted therapy has developed significantly in the last one and half decades, prescribing specific medications for treatment of particular diseases, such as cancer, diabetes, and heart disease. One of the most exciting recent developments in targeted therapies was the isolation of disease-specific molecules from natural resources, such as animal venoms and plant metabolites/toxins, for use as templates for new drug motif designs. In addition, the study of venom proteins/peptides and toxins naturally targeted mammalian receptors and demonstrated high specificity and selectivity towards defined ion channels of cell membranes. Research has also focsed intensely on receptors. The focus of this Special Issue of Toxins addressed the most recent advances using animal venoms, such as frog secretions, bee/ant venoms and plant/fungi toxins, as medicinal therapy. Recent advances in venom/toxin/immunotoxins for targeted cancer therapy and immunotherapy, along with using novel disease-specific venom-based protein/peptide/toxin and currently available FDA-approved drugs for combinationtreatments will be discussed. Finally, we included an overview of select promising toad/snake venom-based peptides/toxins potentially able to address the forthcoming challenges in this field. Both research and review articles proposing novelties or overviews, respectively, were published in this Special Issue after rigorous evaluation and revision by expert peer reviewers.

cane toad --- n/a --- B cell non-Hodgkin lymphoma --- Malaysian cobras --- complement system --- decay accelerating factor --- neuroblastoma --- atopic dermatitis --- complement dependent cytotoxicity --- antioxidant enzymes --- bacterial adhesion --- cancer therapy --- N. kaouthia --- anuran skin secretion --- frog --- Apis mellifera syriaca --- solid phase extraction --- bee venom phospholipase A2 (bvPLA2) --- disintegrin --- toad toxins --- immunotoxins --- ribosome-inactivating proteins --- antimicrobial peptide (AMP) --- drug design --- Moxetumomab pasudotox --- snake venom --- antiviral activity --- in vitro effects --- bombesin-related peptide --- oxidative stress biomarkers --- half-life --- blood vessel formation --- target therapy --- 2 --- MYCN --- indolealkylamines --- Huachansu --- membrane attack complex --- bouganin --- bee venom --- SEM --- anticancer activity --- antimicrobial peptide --- house dust mite extract (DFE) --- mannose receptor --- O. hannah --- bicarinalin --- gastric cells --- melittin --- LC-ESI-MS --- dermaseptin --- smooth muscle --- apoptosis --- anticancer --- N. sumatrana --- Helicobacter pylori --- inflammation --- immunotherapy --- atopic dermatitis (AD) --- immunotoxin --- mantle cell lymphoma --- clearance --- mass spectrometry --- Bougainvillea --- rRNA N-glycosylase activity --- fungal toxin --- skin inflammation --- targeted therapy --- 4-dinitrochlorobenzene (DNCB) --- Bee venom --- VEGF --- Chansu --- bufadienolides --- obsessive–compulsive disorder (OCD) --- BLF1 --- antimicrobial activity --- orellanine --- VB6-845 --- acute lymphoblastic leukemia --- ribosome-inactivating protein --- CD206 --- molecular cloning --- cancer --- CD22 --- eIF4A --- obsessive-compulsive disorder (OCD)